Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is: Hyperthyroidism Thyroiditis Thyroid carcinoma Hypothyroidism None 2. According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range: 200–250 mCi. 100–150 mCi. 50–100 mCi. 150–200 mCi. None 3. Which of the following time is advised for patients treated with 1-131 to delay conception after treatment? 1 month 6 months 4 months 2 months None 4. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Radioimmunotherapy. Radiation therapy. Radiochemotherapy. Antibody therapy. None 5. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Fine needle aspiration biopsy. Surgical removal. Chemotherapy. Radiation therapy. None 6. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Reviewing potential interfering medications Performing pulmonary function tests Blocking thyroid uptake of free radioiodine A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan None 7. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Anemia Fever Arrhythmia Bruising None 8. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Medullary thyroid carcinoma Pain in bony metastases Polycythemia vera Dyspnea in lung Ca None 9. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Radiation pneumonitis Gastritis Myelosuppression Leukemia None 10. An ultimate treatment for patients who are nonresponsive to or cannot tolerate other available therapies for a particular illness and whose prognosis is often poor is called: Standard therapy. Consolidation therapy. Salvage therapy. Retreatment. None 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-03-30T09:35:30+03:00March 30th, 2021| Share This Post With Others! FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. Leave a ReplyCancel reply
Leave a Reply